Kwangdong Phar
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti… Read more
Kwangdong Phar (009290) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.041x
Based on the latest financial reports, Kwangdong Phar (009290) has a cash flow conversion efficiency ratio of 0.041x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩26.03 Billion) by net assets (₩632.20 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kwangdong Phar - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Kwangdong Phar's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Kwangdong Phar Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kwangdong Phar ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Provident Bancorp Inc
NASDAQ:PVBC
|
0.020x |
|
GD Culture Group Limited
NASDAQ:GDC
|
-0.001x |
|
Atria Oyj A
HE:ATRAV
|
0.116x |
|
North East Rubbers Public Company Limited
BK:NER
|
0.042x |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
0.016x |
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
-0.128x |
|
Cloud Live Technology Group Co Ltd
SHE:002306
|
-0.051x |
|
Prabha Energy Limited
NSE:PRABHA
|
N/A |
Annual Cash Flow Conversion Efficiency for Kwangdong Phar (2011–2024)
The table below shows the annual cash flow conversion efficiency of Kwangdong Phar from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩618.27 Billion | ₩-12.15 Billion | -0.020x | +1.46% |
| 2023-12-31 | ₩588.05 Billion | ₩-11.73 Billion | -0.020x | -117.37% |
| 2022-12-31 | ₩547.05 Billion | ₩62.82 Billion | 0.115x | +10.21% |
| 2021-12-31 | ₩527.24 Billion | ₩54.94 Billion | 0.104x | +129.22% |
| 2020-12-31 | ₩502.18 Billion | ₩22.83 Billion | 0.045x | -30.54% |
| 2019-12-31 | ₩447.46 Billion | ₩29.29 Billion | 0.065x | -46.89% |
| 2018-12-31 | ₩430.84 Billion | ₩53.10 Billion | 0.123x | +118.65% |
| 2017-12-31 | ₩416.30 Billion | ₩23.46 Billion | 0.056x | -21.78% |
| 2016-12-31 | ₩399.68 Billion | ₩28.80 Billion | 0.072x | -33.84% |
| 2015-12-31 | ₩377.73 Billion | ₩41.14 Billion | 0.109x | +4.55% |
| 2014-12-31 | ₩314.40 Billion | ₩32.75 Billion | 0.104x | -11.92% |
| 2013-12-31 | ₩290.82 Billion | ₩34.39 Billion | 0.118x | +33.16% |
| 2012-12-31 | ₩267.27 Billion | ₩23.74 Billion | 0.089x | -19.93% |
| 2011-12-31 | ₩249.52 Billion | ₩27.68 Billion | 0.111x | -- |